Multidrug resistance-associated protein in acute myeloid leukemia: No impact on treatment outcome

Clinical Cancer Research

Volumn 3, Issue 8, 1997, Pages 1419-1425

  Filipits, Martin ^a   Suchomel, Ralf W ^a   Zöchbauer, Sabine ^a   Brunner, Raoul ^a   Lechner, Klaus ^a   Pirker, Robert ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; TUMOR PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CANCER SURVIVAL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW; CELL LINE; CYTARABINE; DAUNORUBICIN; DISEASE-FREE SURVIVAL; DRUG RESISTANCE, MULTIPLE; ETOPOSIDE; FEMALE; HUMANS; KARYOTYPING; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; P-GLYCOPROTEIN; PROGNOSIS; REMISSION INDUCTION; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; TUMOR CELLS, CULTURED;

EID: 0030811596     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Pastan, I., and Gottesman, M. Multiple-drug resistance in human cancer. N. Engl. J. Med., 316: 1388-1393, 1987.
2. Sato, H., Preisler, H., Day, R., Raza, A., Larson, R., Browman, G., Goldberg, J., Vogler, R., Grunwald, H., Gottlieb, A., Bennett, J., Gottesman, M., and Pastan, I. MDR1 transcript levels as an indication of resistant disease in acute myelogenous leukaemia. Br. J. Haematol., 75: 340-345, 1990.
3. Pirker, R., Wallner, J., Geissler, K., Linkesch, W., Haas, O. A., Bettelheim, P., Hopfner, M., Scherrer, R., Valent, P., Havelec, L., Ludwig, H., and Lechner, K. MDR1 gene expression and treatment outcome in acute myeloid leukemia. J. Natl. Cancer Inst., 83: 708-712, 1991.
4. Marie, J-P., Zittoun, R., and Sikic, B. I. Multidrug resistance (mdr 1) gene expression in adult acute leukemias: correlations with treatment outcome and in vitro drug sensitivity. Blood. 78: 586-592, 1991.
5. Campos, L., Guyotat, D., Archimbaud, E., Calmard-Oriol, P., Tsuruo, T., Troncy, J., Treille, D., and Fiere, D. Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis. Blood, 79: 473-476, 1992.
6. Zöchbauer, S., Gsur, A., Brunner, R., Kyrle, P. A., Lechner, K., and Pirker, R. P-glycoprotein expression as unfavorable prognostic factor in acute myeloid leukemia. Leukemia (Baltimore), 8: 974-977, 1994.
7. Simon, S. M., and Schindler, M. Cell biological mechanisms of multidrug resistance in tumors. Proc. Natl. Acad. Sci. USA. 91: 3497-3504, 1994.
8. Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V., and Deeley, R. G. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science (Washington DC), 258: 1650-1654, 1992.
9. Grant, C. E., Valdimarsson, G., Hipfner, D. R., Almquist, K. C., Cole, S. P. C., and Deeley, R. G. Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res., 54: 357-361, 1994.
10. Cole, S. P. C., Sparks, K. E., Fraser, K., Loe, D. W., Grant, C. E., Wilson, G. M., and Deeley, R. G. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res., 54: 5902-5910, 1994.
11. Filipits, M., Suchomel, R. W., Zöchbauer, S., Malayeri, R., and Pirker, R. Clinical relevance of drug resistance genes in malignant diseases. Leukemia (Baltimore), 10 (Suppl. 3): 10-17, 1996.
12. Filipits, M., Suchomel, R. W., Dekan, G., Haider, K., Valdimarsson, G., Depisch, D., and Pirker, R. MRP and MDR1 gene expression in primary breast carcinomas. Clin. Cancer Res., 2: 1231-1237, 1996.
13. r 190,000 multidrug resistance protein, MRP, with monoclonal antibodies. Cancer Res., 54: 5788-5792, 1994.
14. Haas, O. A., Schwarzmeier, J. D., Nacheva, E., Fischer, P., and Paietta, E. Investigations on karyotype evolution in patients with chronic myeloid leukemia (CML). Blut, 48: 33-43, 1984.
15. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
16. Zöchbauer, S., Haas, O. A., Schwarzinger, I., Lechner, K., and Pirker, R. Multidrug resistance in acute myeloid leukaemia with inversion in chromosome 16 or FAB M4Eo subtype. Lancet, 344: 894, 1994.
17. Legrand, O., Perrot, J-Y., Tang, R. P., Simonin, G., Gurbuxani, S., Zittoun, R., and Marie, J-P. Expression of the multidrug resistance-associated protein (MRP) mRNA and protein in normal peripheral blood and bone marrow haemopoietic cells. Br. J. Haematol., 94: 23-33, 1996.
18. Hart, S. M., Ganeshaguru, K., Hoffbrand, A. V., Prentice, H. G., and Mehta, A. B. Expression of the multidrug resistance-associated protein (MRP) in acute leukaemia. Leukemia (Baltimore), 8: 2163-2168, 1994.
19. Schneider, E., Cowan, K. H., Bader, H., Toomey, S., Schwartz, G. N., Karp, J. E., Burke, P. J., and Kaufmann, S. H. Increased expression of the multidrug resistance-associated protein gene in relapsed acute leukemia. Blood, 85: 186-193, 1995.
20. Zhou, D-C., Zittoun, R., and Marie, J-P. Expression of multidrug resistance-associated protein (MRP) and multidrug resistance (MDR1) genes in acute myeloid leukemia. Leukemia (Baltimore). 9: 1661-1666, 1995.
21. Ross, D. D., Doyle, L. A., Schiffer, C. A., Lee, E. J., Grant, C. E., Cole, S. P. C., Deeley, R. G., Yang, W., and Tong, Y. Expression of multidrug resistance-associated protein (MRP) mRNA in blast cells from acute myeloid leukemia (AML) patients. Leukemia (Baltimore), 10: 48-55, 1996.
22. Burger, H., Nooter, K., Zaman, G. J. R., Sonneveld, P., van Wingerden, K. E., Oostrum, R. G., and Stoter, G. Expression of the multidrug resistance-associated protein (MRP) in acute and chronic leukemias. Leukemia (Baltimore), 8: 990-997, 1994.
23. Schuurhuis, G. J., Broxterman, H. J., Ossenkoppele, G. J., Baak, J. P. A., Eekman, C. A., Kuiper, C. M., Feller, N., van Heijningen, T. H. M., Klumper, E., Pieters, R., Lankelma, J., and Pinedo, H. M. Functional multidrug resistance phenotype associated with combined overexpression of Pgp/MDR1 and MRP together with 1-β-D-arabinofuranosylcytosine sensitivity may predict clinical response in acute myeloid leukemia. Clin. Cancer Res., 1: 81-93, 1995.
24. Nooter, K., Westerman, A. M., Flens, M. J., Zaman, G. J. R., Scheper, R. J., van Wingerden, K. E., Burger, H., Oostrum, R., Boersma, T., Sonneveld, P., Gratama, J. W., Kok, T., Eggermont, A. M. M., Bosman, F. T., and Stoter, G. Expression of the multidrug resistance-associated protein (MRP) gene in human cancers. Clin. Cancer Res., 1: 1301-1310, 1995.
25. Kuss, B. J., Deeley, R. G., Cole, S. P. C., Willman, C. L., Kopecky, K. J., Wolman, S. R., Eyre, H. J., Lane, S. A., Nancarrow, J. K., Whitmore, S. A., and Callen, D. F. Deletion of gene for multidrug resistance in acute myeloid leukaemia with inversion in chromosome 16: prognostic implications. Lancet, 343: 1531-1534, 1994.
26. Norris, M. D., Bordow, S. B., Marshall, G. M., Haber, P. S., Cohn, S. L., and Haber, M. Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma. N. Engl. J. Med., 334: 231-238, 1996.
27. Ota, E., Abe, Y., Oshika, Y., Ozeki, Y., Iwasaki, M., Inoue, H., Yamazaki, H., Ueyama, Y., Takagi, K., Ogata, T., Tamaoki, N., and Nakamura, M. Expression of the multidrug resistance-associated protein (MRP) gene in non-small-cell lung cancer. Br. J. Cancer, 72: 550-554, 1995.
28. Izquierdo, M. A., van der Zee, A. G. J., Vermorken, J. B., van der Valk, P., Belien, J. A. M., Giaccone, G., Scheffer, G. L., Flens, M. J., Pinedo, H. M., Kenemans, P., Meijer, C. J. L. M., de Vries, E. G. E., and Scheper, R. J. Drug resistance-associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma. J. Natl. Cancer Inst., 87: 1230-1237, 1995.
29. Filipits, M., Suchomel, R. W., Dekan, G., Stiglbauer, W., Haider, K., Depisch, D., and Pirker, R. Expression of the multidrug resistance-associated protein (MRP) gene in colorectal carcinomas. Br. J. Cancer. 75: 208-212, 1997.
30. Fojo, A. T., Ueda, K., Slamon, D. J., Poplack, D. G., Gottesman, M. M., and Pastan, I. Expression of a multidrug-resistance gene in human tumors and tissues. Proc. Natl. Acad. Sci. USA. 84: 265-269, 1987.
31. Goldstein, L. J., Galski, H., Fojo, A., Willingham, M., Lai, S-L., Gazdar, A., Pirker, R., Green, A., Crist, W., Brodeur, G. M., Lieber, M., Cossman, J., Gottesman, M. M., and Pastan, I. Expression of a multidrug resistance gene in human cancers. J. Natl. Cancer Inst., 81: 116-124, 1989.
32. Beck, W. T. The cell biology of multiple drug resistance. Biochem. Pharmacol., 36: 2879-2887, 1987.
33. Tew, K. D. Glutathione-associated enzymes in anticancer drug resistance. Cancer Res., 54: 4313-4320, 1994.
34. List, A. F., Spier, C. S., Grogan, T. M., Johnson, C., Roe, D. J., Greer, J. P., Wolff, S. N., Broxterman, H. J., Scheffer, G. L., Scheper, R. J., and Dalton, W. S. Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemia. Blood, 87: 2464-2469, 1996.
35. Twentyman, P. R. MDR1 (P-glycoprotein) gene expression: implications for resistance modifier trials. J. Natl. Cancer Inst., 84: 1458-1460, 1992.
36. Sikic, B. I. Modulation of multidrug resistance: at the threshold. J. Clin. Oncol., 11: 1629-1635, 1993.
37. Malayeri, R., Filipits, M., Suchomel, R. W., Zöchbauer, S., Lechner, K., and Pirker, R. Multidrug resistance in leukemias and its reversal. Leuk. & Lymphoma, 23: 451-458, 1997.
38. List, A. F., Spier, C., Greer, J., Wolff, S., Hutter, J., and Dorr, R. Phase I/II trial of cyclosporine as a chemotherapy resistance modifier in acute leukemia. J. Clin. Oncol., 11: 1652-1660, 1993.
39. Pirker, R., Zöchbauer, S., Kupper, H., Lassmann, A., Gsur, A., and Frass, M. Dexverapamil as resistance modifier in acute myeloid leukaemia. J. Cancer Res. Clin. Oncol., 121 (Suppl. 3): 21-24, 1995.